Form 4 for ZVRA ZEVRA THERAPEUTICS, INC.
Accepted 2024-07-17 00:00:00 ET · period of report 2024-07-17 · accession 0001437749-24-022939 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-07-17 | 2024-07-17 | ZVRA | Clifton R. LaDuane | CFO, Treas | P - Purchase | $6.77 | +2,000 | 18.5K | +12% | +$13.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-07-17 | P | A | 2,000 | $6.77 | 18,469 | D | — | — |